Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
36779 | 74 | 37.2 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
304 | 3 | P53//RETINOBLASTOMA//MDM2 | 40663 |
483 | 2 | CYCLIN DEPENDENT KINASE//CELL CYCLE//CDK5 | 15640 |
36779 | 1 | CDK11P58//PITSLRE//CDK11 | 74 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CDK11P58 | authKW | 5559834 | 22% | 84% | 16 |
2 | PITSLRE | authKW | 2934358 | 11% | 89% | 8 |
3 | CDK11 | authKW | 1684958 | 9% | 58% | 7 |
4 | AUTOPHAGY CANC TEAMEDINBURGH CANC UK | address | 412644 | 1% | 100% | 1 |
5 | CARBOXYL TERMINAL DOMAIN OF THE LARGEST SUBUNIT OF | authKW | 412644 | 1% | 100% | 1 |
6 | CDC2L2 | authKW | 412644 | 1% | 100% | 1 |
7 | CDK11P110 | authKW | 412644 | 1% | 100% | 1 |
8 | CDKS INHIBITOR | authKW | 412644 | 1% | 100% | 1 |
9 | CYCLIN DEPENDENT KINASE 11 CDK11 | authKW | 412644 | 1% | 100% | 1 |
10 | DYNEIN LIGHT CHAIN 2 | authKW | 412644 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 266 | 50% | 0% | 37 |
2 | Cell Biology | 214 | 28% | 0% | 21 |
3 | Genetics & Heredity | 81 | 15% | 0% | 11 |
4 | Oncology | 58 | 16% | 0% | 12 |
5 | Biophysics | 41 | 9% | 0% | 7 |
6 | Biotechnology & Applied Microbiology | 6 | 5% | 0% | 4 |
7 | Immunology | 4 | 5% | 0% | 4 |
8 | Reproductive Biology | 2 | 1% | 0% | 1 |
9 | Developmental Biology | 2 | 1% | 0% | 1 |
10 | Respiratory System | 1 | 1% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AUTOPHAGY CANC TEAMEDINBURGH CANC UK | 412644 | 1% | 100% | 1 |
2 | GENET MOL CIENCIAS FISIOL 1 | 412644 | 1% | 100% | 1 |
3 | IFR140HOP PONTCHAILLOU | 412644 | 1% | 100% | 1 |
4 | JIANGSU PROV NEUROGENERAT | 412644 | 1% | 100% | 1 |
5 | JIANGSU PROV NEUROREGENERAGT | 412644 | 1% | 100% | 1 |
6 | KE GLYCOCONJUGATE GENE | 412644 | 1% | 100% | 1 |
7 | SCI INGN BIOL SANTE IFR148 | 412644 | 1% | 100% | 1 |
8 | U REGULAT EQUILIB FONCT FOIE NORMAL PATHOL 5 | 412644 | 1% | 100% | 1 |
9 | UMR FOIE 991 | 412644 | 1% | 100% | 1 |
10 | MOL VIRUS | 206321 | 1% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELL CYCLE | 2508 | 3% | 0% | 2 |
2 | PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY | 774 | 1% | 0% | 1 |
3 | MOLECULAR AND CELLULAR BIOCHEMISTRY | 704 | 5% | 0% | 4 |
4 | INFLAMMATION | 634 | 3% | 0% | 2 |
5 | JOURNAL OF BIOLOGICAL CHEMISTRY | 608 | 20% | 0% | 15 |
6 | CANCER CELL INTERNATIONAL | 537 | 1% | 0% | 1 |
7 | GENOMICS | 445 | 4% | 0% | 3 |
8 | JOURNAL OF MOLECULAR DIAGNOSTICS | 360 | 1% | 0% | 1 |
9 | GENE | 336 | 5% | 0% | 4 |
10 | DIABETES-METABOLISM RESEARCH AND REVIEWS | 286 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CDK11P58 | 5559834 | 22% | 84% | 16 | Search CDK11P58 | Search CDK11P58 |
2 | PITSLRE | 2934358 | 11% | 89% | 8 | Search PITSLRE | Search PITSLRE |
3 | CDK11 | 1684958 | 9% | 58% | 7 | Search CDK11 | Search CDK11 |
4 | CARBOXYL TERMINAL DOMAIN OF THE LARGEST SUBUNIT OF | 412644 | 1% | 100% | 1 | Search CARBOXYL+TERMINAL+DOMAIN+OF+THE+LARGEST+SUBUNIT+OF | Search CARBOXYL+TERMINAL+DOMAIN+OF+THE+LARGEST+SUBUNIT+OF |
5 | CDC2L2 | 412644 | 1% | 100% | 1 | Search CDC2L2 | Search CDC2L2 |
6 | CDK11P110 | 412644 | 1% | 100% | 1 | Search CDK11P110 | Search CDK11P110 |
7 | CDKS INHIBITOR | 412644 | 1% | 100% | 1 | Search CDKS+INHIBITOR | Search CDKS+INHIBITOR |
8 | CYCLIN DEPENDENT KINASE 11 CDK11 | 412644 | 1% | 100% | 1 | Search CYCLIN+DEPENDENT+KINASE+11+CDK11 | Search CYCLIN+DEPENDENT+KINASE+11+CDK11 |
9 | DYNEIN LIGHT CHAIN 2 | 412644 | 1% | 100% | 1 | Search DYNEIN+LIGHT+CHAIN+2 | Search DYNEIN+LIGHT+CHAIN+2 |
10 | HIGH FIVE INSECT CELL | 412644 | 1% | 100% | 1 | Search HIGH+FIVE+INSECT+CELL | Search HIGH+FIVE+INSECT+CELL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JI, YH , XIAO, F , SUN, LL , QIN, J , SHI, SX , YANG, JL , LIU, YH , ZHOU, D , ZHAO, J , SHEN, A , (2008) INCREASED EXPRESSION OF CDK11(P58) AND CYCLIN D3 FOLLOWING SPINAL CORD INJURY IN RATS.MOLECULAR AND CELLULAR BIOCHEMISTRY. VOL. 309. ISSUE 1-2. P. 49 -60 | 19 | 53% | 4 |
2 | ZHOU, YB , SHEN, JK , HORNICEK, FJ , KAN, QC , DUAN, ZF , (2016) THE EMERGING ROLES AND THERAPEUTIC POTENTIAL OF CYCLIN-DEPENDENT KINASE 11 (CDK11) IN HUMAN CANCER.ONCOTARGET. VOL. 7. ISSUE 26. P. 40846 -40859 | 27 | 29% | 0 |
3 | CHI, YY , ZHANG, CY , ZONG, HL , HONG, Y , KONG, XF , LIU, HO , ZOU, WY , WANG, YL , YUN, XJ , GU, JX , (2011) THR-370 IS RESPONSIBLE FOR CDK11(P58) AUTOPHOSPHORYLATION, DIMERIZATION, AND KINASE ACTIVITY.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 286. ISSUE 3. P. 1748 -1757 | 15 | 54% | 5 |
4 | LOYER, P , TREMBLEY, JH , GRENET, JA , BUSSON, A , CORLU, A , ZHAO, W , KOCAK, M , KIDD, VJ , LAHTI, JM , (2008) CHARACTERIZATION OF CYCLIN L1 AND L2 INTERACTIONS WITH CDK11 AND SPLICING FACTORS - INFLUENCE OF CYCLIN L ISOFORMS ON SPLICE SITE SELECTION.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 283. ISSUE 12. P. 7721-7732 | 15 | 50% | 37 |
5 | HAO, YQ , KONG, XF , RUAN, YY , GAN, HC , CHEN, H , ZHANG, CY , REN, SF , GU, JX , (2011) CDK11P46 AND RPS8 ASSOCIATE WITH EACH OTHER AND SUPPRESS TRANSLATION IN A SYNERGISTIC MANNER.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 407. ISSUE 1. P. 169 -174 | 15 | 43% | 4 |
6 | CHANDRAMOULI, A , SHI, J , FENG, Y , HOLUBEC, H , SHANAS, RM , BHATTACHARYYA, AK , ZHENG, W , NELSON, MA , (2007) HAPLOINSUFFICIENCY OF THE CDC21 GENE CONTRIBUTES TO SKIN CANCER DEVELOPMENT IN MICE.CARCINOGENESIS. VOL. 28. ISSUE 9. P. 2028-2035 | 14 | 42% | 11 |
7 | SHI, JQ , NELSON, MA , (2005) THE CYCLIN-DEPENDENT KINASE 11 INTERACTS WITH NOT2.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 334. ISSUE 4. P. 1310-1316 | 12 | 52% | 6 |
8 | FENG, YM , ARIZA, ME , GOULET, AC , SHI, JQ , NELSON, MA , (2005) DEATH-SIGNAL-INDUCED RELOCALIZATION OF CYCLIN-DEPENDENT KINASE 11 TO MITOCHONDRIA.BIOCHEMICAL JOURNAL. VOL. 392. ISSUE . P. 65-73 | 13 | 46% | 10 |
9 | ZHOU, YB , HAN, C , LI, DL , YU, ZJ , LI, FM , LI, F , AN, Q , BAI, HL , ZHANG, XJ , DUAN, ZF , ET AL (2015) CYCLIN-DEPENDENT KINASE 11(P110) (CDK11(P110)) IS CRUCIAL FOR HUMAN BREAST CANCER CELL PROLIFERATION AND GROWTH.SCIENTIFIC REPORTS. VOL. 5. ISSUE . P. - | 15 | 31% | 2 |
10 | CHI, YY , HUANG, S , PENG, HJ , LIU, MY , ZHAO, J , SHAO, ZM , WU, J , (2015) CRITICAL ROLE OF CDK11(P58) IN HUMAN BREAST CANCER GROWTH AND ANGIOGENESIS.BMC CANCER. VOL. 15. ISSUE . P. - | 12 | 36% | 1 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 16451 | BETA 1 4 GALACTOSYLTRANSFERASE I//GALACTOSYLTRANSFERASE//BETA 1 4 GALACTOSYLTRANSFERASE |
2 | 31511 | RANBPM//RANBP9//IMMUNEREGULAT |
3 | 23426 | CELLULAR HEMOSTASIS//NEVOCELLULAR NEVI//SKIN DIS PROGRAM |
4 | 37421 | BCL2L12//BCL2L12A//BRAIN TUMOR GENET MED |
5 | 5889 | P TEFB//CDK9//RNA POLYMERASE II |
6 | 34552 | CCNG2//CYCLIN G2//CYCLIN G |
7 | 7118 | FLAVOPIRIDOL//CYCLIN DEPENDENT KINASE//ROSCOVITINE |
8 | 23606 | CAK//SPY1//CDK ACTIVATING KINASE |
9 | 11502 | PAK1//P21 ACTIVATED KINASE//PAK4 |
10 | 11551 | CDK5//P35//CYCLIN DEPENDENT KINASE 5 |